Sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischaemic injury

Nature Biomedical Engineering

Volumn 1, Issue 12, 2017, Pages 983-992

  Wang, Leo L ^a   Liu, Ying ^b   Chung, Jennifer J ^b   Wang, Tao ^b   Gaffey, Ann C ^b   Lu, Minmin ^b   Cavanaugh, Christina A ^b   Zhou, Su ^b   Kanade, Rahul ^b   Atluri, Pavan ^b   Morrisey, Edward E ^b   Burdick, Jason A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85035088950     PISSN: None     EISSN: 2157846X     Source Type: Journal    
DOI: 10.1038/s41551-017-0157-y     Document Type: Article

References (55)

1. Townsend, N. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 37, 3232-3245 (2016).
2. Mozaffarian, D. et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation 131, e29-322 (2014).
3. Pasumarthi, K. B. S. Cardiomyocyte cell cycle regulation. Circ. Res. 90, 1044-1054 (2002).
4. Jameel, M. N. & Zhang, J. Stem cell therapy for ischaemic heart disease. Antioxid. Redox Signal. 13, 1879-1897 (2010).
5. Leone, M., Magadum, A. & Engel, F. B. Cardiomyocyte proliferation in cardiac development and regeneration: a guide to methodologies and interpretations. Am. J. Physiol. Heart Circ. Physiol. 309, H1237-H1250 (2015).
6. Laflamme, M. A. & Murry, C. E. Heart regeneration. Nature 473, 326-335 (2011).
7. Li, Y. et al. Acute myocardial infarction induced functional cardiomyocytes to re-enter the cell cycle. Am. J. Transl. Res. 5, 327-335 (2013).
8. Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
9. Elnakish, M. T. et al. Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int. 2012, 1-14 (2012).
10. Gavira, J. J. et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J. Thorac. Cardiovasc. Surg. 131, 799-804 (2006).
11. Hodgson, D. M. et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 287, H471-H479 (2004).
12. Lalit, P. A., Hei, D. J., Raval, A. N. & Kamp, T. J. Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ. Res. 114, 1328-1345 (2014).
13. Korf-Klingebiel, M. et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat. Med. 21, 140-149 (2015).
14. Ni, T. T. et al. Discovering small molecules that promote cardiomyocyte generation by modulating Wnt signaling. Chem. Biol. 18, 1658-68 (2011).
15. Cheng, Y.-Y. et al. Reprogramming-derived gene cocktail increases cardiomyocyte proliferation for heart regeneration. EMBO Mol. Med. 9, 251-264 (2017).
16. Liang, D. et al. miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2. Int. J. Cardiol. 201, 38-48 (2015).
17. Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
18. Tian, Y. et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci. Transl. Med. 7, 279ra38 (2015).
19. Panda, N. C. et al. Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel. J. Interv. Card. Electrophysiol. 41, 117-127 (2014).
20. Teng, C. J., Luo, J., Chiu, R. C. J. & Shum-Tim, D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J. Thorac. Cardiovasc. Surg. 132, 628-632 (2006).
21. Tous, E., Purcell, B., Ifkovits, J. L. & Burdick, J. A. Injectable acellular hydrogels for cardiac repair. J. Cardiovasc. Transl. Res. 4, 528-542 (2011).
22. Gaffey, A. C. et al. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischaemic myocardium. J. Thorac. Cardiovasc. Surg. 150, 1268-1277 (2015).
23. Rodell, C. B. et al. Shear-thinning supramolecular hydrogels with secondary autonomous covalent crosslinking to modulate viscoelastic properties in vivo. Adv. Funct. Mater. 25, 636-644 (2014).
24. Rodell, C. B., Kaminski, A. L. & Burdick, J. A. Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels. Biomacromolecules 14, 4125-4134 (2013).
25. Rodell, C. B. et al. Injectable shear-thinning hydrogels for minimally invasive delivery to infarcted myocardium to limit left ventricular remodeling. Circ. Cardiovasc. Interv. 9, e004058 (2016).
26. Wang, L. L. et al. Injectable, guest-host assembled polyethylenimine hydrogel for siRNA delivery. Biomacromolecules 18, 77-86 (2016).
27. Seif-Naraghi, S. B. et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med. 5, 173ra25 (2013).
28. Guvendiren, M., Lu, H. D. & Burdick, J. A. Shear-thinning hydrogels for biomedical applications. Soft Matter 8, 260-272 (2012).
29. Mealy, J. E., Rodell, C. B. & Burdick, J. A. Sustained small molecule delivery from injectable hyaluronic acid hydrogels through host-guest mediated retention. J. Mater. Chem. B 3, 8010-8019 (2015).
30. Liu, Y. M. et al. Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy. BMC Cancer 14, 889 (2014).
31. Shim, M. S. & Kwon, Y. J. Efficient and targeted delivery of siRNA in vivo. FEBS J. 277, 4814-27 (2010).
32. Wolfrum, C. et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25, 1149-1157 (2007).
33. Wang, L. L. & Burdick, J. A. Engineered hydrogels for local and sustained delivery of RNA-interference therapies. Adv. Healthc. Mater. 6, 1601041 (2016).
34. van de Manakker, F., van der Pot, M., Vermonden, T., van Nostrum, C. F. & Hennink, W. E. Self-assembling hydrogels based on β-cyclodextrin/cholesterol inclusion complexes. Macromolecules 41, 1766-1773 (2008).
35. Lápez, C. A. et al. Molecular mechanism of cyclodextrin mediated cholesterol extraction. PLoS Comput. Biol. 7, e1002020 (2011).
36. Politzer, I. R. et al. Effect of β-cyclodextrin on the fluorescence, absorption and lasing of rhodamine 6G, rhodamine B and fluorescein disodium salt in aqueous solutions. Chem. Phys. Lett. 159, 258-262 (1989).
37. Mondal, A. & Jana, N. R. Fluorescent detection of cholesterol using β-cyclodextrin functionalized graphene. Chem. Commun. 48, 7316 (2012).
38. Lápez, C. A., de Vries, A. H. & Marrink, S. J. Molecular mechanism of cyclodextrin mediated cholesterol extraction. PLoS Comput. Biol. 7, e1002020 (2011).
39. Senyo, S. E. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433-436 (2012).
40. Ali, S. R. et al. Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc. Natl Acad. Sci. USA 111, 8850-8855 (2014).
41. Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134-144 (2010).
42. Lescroart, F. et al. Early lineage restriction in temporally distinct populations of Mesp1 progenitors during mammalian heart development. Nat. Cell Biol. 16, 829-840 (2014).
43. Rios, A. C., Fu, N. Y., Lindeman, G. J. & Visvader, J. E. In situ identification of bipotent stem cells in the mammary gland. Nature 506, 322-327 (2014).
44. Sohal, D. S. et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20-25 (2001).
45. Frank, D. B. et al. Emergence of a wave of Wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation. Cell Rep. 17, 2312-2325 (2016).
46. Farin, H. F. et al. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 530, 340-343 (2016).
47. Farin, H. F., Van Es, J. H. & Clevers, H. Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 143, 1518-1529.e7 (2012).
48. Burdick, J. A. & Prestwich, G. D. Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23, H41-H56 (2011).
49. Tian, Y. & Morrisey, E. E. Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ. Res. 110, 1023-1034 (2012).
50. Yang, Y. et al. MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ. Res. 117, 450-459 (2015).
51. Lesizza, P. et al. Single-dose intracardiac injection of pro-regenerative microRNAs improves cardiac function after myocardial infarction. Circ. Res. 120, 1298-1304 (2017).
52. Monaghan, M. G. et al. Exogenous miR-29B delivery through a hyaluronanbased injectable system yields functional maintenance of the infarcted myocardium. Tissue Eng. Part A https://doi.org/10.1089/ten.TEA.2016.0527 (2017).
53. Pandey, R. et al. MicroRNA-1825 induces proliferation of adult cardiomyocytes and promotes cardiac regeneration post ischaemic injury. Am. J. Transl. Res. 9, 3120-3137 (2017).
54. Patel, R. S. et al. High resolution of microRNA signatures in human whole saliva. Arch. Oral Biol. 56, 1506-1513 (2011).
55. Shcherbakova, D. M. & Verkhusha, V. V. Near-infrared fluorescent proteins for multicolor in vivo imaging. Nat. Methods 10, 751-754 (2013).